This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Université Pierre Et Marie Curie (Paris 6). Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Gila Maor: Innovator in Peptide Research
Introduction
Gila Maor is a notable inventor based in Illinois, recognized for her contributions to the field of peptide research. Despite having no patents to her name, her work focuses on the modulation of IGF-1 activity, which has significant implications for medical science.
Latest Patents
Gila Maor's latest patents include "Peptides Modulant L'activite De L'igf-1 Et Leurs Applications." This invention relates to peptides that can modulate the activity of IGF-1, along with a pharmaceutical composition containing these peptides. The applications of this invention extend to their use as medicaments and agents for the in vitro modulation of cellular proliferation. Another significant patent is "Peptides For Inhibiting Igf-1," which involves peptides useful for inhibiting IGF-1 activity. This invention is aimed at providing agents for the inhibition of in vitro cell proliferation and for the treatment of various diseases.
Career Highlights
Throughout her career, Gila Maor has focused on innovative research that bridges the gap between basic science and practical applications in medicine. Her work has the potential to influence therapeutic strategies for diseases related to cellular proliferation.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Gila Maor's research in peptide modulation of IGF-1 activity showcases her innovative spirit and dedication to advancing medical science. Her contributions, although not yet reflected in patents, hold promise for future developments in therapeutic applications.